Catalog No.
Product Name
Application
Product Information
Citations
-
HBV Inhibitor
HBV-IN-23 is a potent inhibitor of Hepatitis B virus (HBV) DNA replication with an IC50 of 0.58 μM. This compound effectively inhibits HBV replication across both sensitive and resistant strains. Additionally, HBV-IN-23 demonstrates anti-hepatocellular carcinoma activity by inducing apoptosis in HepG2 cells, making it a valuable tool for research into HBV and related hepatic conditions. -
Parasite Inhibitor
Quinacrine acetate is a potent modulator of the cGAS-STING-TBK1 signaling pathway, exhibiting notable immune stimulatory activity. This compound has been investigated for its therapeutic potential in enhancing anti-tumor immunity and improving the efficacy of cancer immunotherapies by addressing the immunogenicity challenges faced by various tumors. Quinacrine acetate also represents a promising approach to mitigate the limitations associated with immune checkpoint inhibitors in cancer treatment. -
Anti-tumour Antibiotic
Boanmycin is an anti-tumor antibiotic that exerts its biological activity by inducing cellular senescence and apoptosis in cancer cells. This compound is primarily utilized in research to explore mechanisms of tumor suppression and to assess its potential therapeutic applications in oncology. Its ability to promote programmed cell death makes it a valuable tool for studying cancer biology and developing novel treatment strategies. -
Antifungal Agent
Sertaconazole is a broad-spectrum topical antifungal agent that primarily targets fungal cell membranes. It exhibits significant anti-inflammatory activity by activating the p38-COX-2-PGE2 signaling pathway. Additionally, Sertaconazole functions as a microtubule inhibitor, demonstrating antiproliferative effects, and inducing apoptosis and autophagy. Its ability to inhibit cellular migration makes it valuable in various research applications related to fungal infections and inflammatory conditions. -
Antibiotic
4-Epianhydrotetracycline hydrochloride is an antibiotic that serves as a significant intermediate in tetracycline synthesis. It demonstrates cytotoxic effects and induces apoptosis in zebrafish embryos, highlighting its potential for developmental toxicology studies. Furthermore, it exhibits antimicrobial activity against Shewanella, Escherichia coli, and Pseudomonas aeruginosa, with minimum inhibitory concentrations of 2 mg/L, 1 mg/L, and 64 mg/L, respectively, indicating its utility in microbial resistance research. -
Bacterial Metabolite Xie
Collismycin A is a bacterial metabolite targeting multiple cellular pathways, originally isolated from Streptomyces. Exhibiting antibacterial, antiproliferative, and neuroprotective properties, it demonstrates activity against various bacteria and fungi (MICs ranging from 6.25 to 100 μg/mL). Notably, Collismycin A inhibits the proliferation of A549 lung, HCT116 colon, and HeLa cervical cancer cells, with IC50 values of 0.3, 0.6, and 0.3 μM, respectively, while demonstrating minimal impact on MDA-MB-231 breast cancer cells (IC50 > 100 μM). Furthermore, it forms a complex with Fe(II) and Fe(III) at a 2:1 ratio, where the presence of iron ions can attenuate its antiproliferative effects in HeLa cells, and it exhibits protective effects against neuronal cell death in zebrafish larvae models. -
Antibacterial Agent/eEF2K Inhibitor
Cefatrizine is a broad-spectrum cephalosporin antibiotic that primarily targets bacterial infections while also acting as an eEF2K inhibitor. This compound exhibits anti-proliferative activity in human breast cancer cells, inducing endoplasmic reticulum stress and subsequent cell death. Cefatrizine is a valuable reagent for research applications in understanding mechanisms of cancer therapy and exploring antibacterial efficacy. -
Ras Inhibitor
(-)-Rasfonin is a natural fungal secondary metabolite that acts as an inhibitor of small G protein Ras. It exhibits significant biological activities, including the induction of apoptosis, necrosis, and autophagy in ACHN cells, a renal carcinoma cell line. This compound is instrumental for research focused on cellular death pathways and therapeutic strategies targeting Ras-mediated signaling in cancer. -
Antibiotic
Deoxynybomycin is an antibiotic that acts as an inhibitor of DNA gyrase and Topoisomerase I. It demonstrates significant antibacterial activity against Staphylococcus aureus and induces the expression of p21/WAF1. Additionally, Deoxynybomycin exhibits cytotoxic effects and promotes apoptosis in various cancer cell lines, including Saos-2, TMK-1, and THP-1, making it a valuable tool for research in antimicrobial and cancer biology. -
Anti-tumour Antibiotic
Boanmycin hydrochloride is an anti-tumor antibiotic that exhibits significant cytotoxic effects against various cancer cell lines. It functions by inducing cellular senescence and apoptosis, making it a valuable tool for studying mechanisms of tumor progression and resistance. This compound is useful in cancer research and can aid in the development of therapeutic strategies targeting malignant cells. -
Antibiotic
Undecylprodigiosin hydrochloride is an antibiotic derived from the prodiginine class of compounds. It exhibits potent antimicrobial activity and selectively induces apoptosis in human breast carcinoma cells through a p53-independent mechanism. Additionally, this compound demonstrates immunosuppressive and anticancer properties, making it a valuable tool for research in cancer therapy and microbial studies. -
Antitumor Antibiotic
Antibiotic DC 81 is a potent antitumor antibiotic derived from Streptomyces species, classified as a pyrrolo[2,1-c][1,4]benzodiazepine (PBD). It functions primarily as an inhibitor of nucleic acid synthesis by recognizing and binding to specific DNA sequences, resulting in the formation of a labile covalent adduct. This ability to interact with DNA makes Antibiotic DC 81 valuable for research in cancer biology and the development of novel therapeutic agents targeting DNA. -
Antibacterial Agent
Chlorhexidine acetate hydrate is a cationic antimicrobial agent that targets microbial cell membranes. By non-specifically binding to cell membrane phospholipids, it disrupts membrane integrity, leading to leakage of cellular contents and bacterial cell death. This compound exhibits broad-spectrum bactericidal activity against both Gram-positive and Gram-negative bacteria. Its ability to interfere with membrane permeability and induce protein precipitation makes it valuable for research applications focused on microbial growth inhibition and mechanisms of cell death. -
Azoxystrobin Enantiomer
(Z)-Azoxystrobin is an enantiomer of Azoxystrobin, a broad-spectrum β-methoxyacrylate fungicide. It functions by inhibiting mitochondrial respiration through binding to the Qo site of the cytochrome bc1 complex, thereby disrupting electron transfer. The compound is known to induce the production of reactive oxygen species (ROS), ultimately leading to cell apoptosis. It is primarily used in research applications involving fungal inhibition and the study of mitochondrial function. -
Antibiotic
FSL-1 is a bacterial-derived agonist of toll-like receptor 2/6 (TLR2/6). It exhibits immunostimulatory activity that enhances resistance against experimental Herpes Simplex Virus Type 2 (HSV-2) infection. This compound is valuable for research applications focused on innate immunity and the development of therapeutic strategies for viral infections. -
β-lactamase Inhibitor
RDR 02308 is a β-lactamase inhibitor that targets the TLR4-MyD88 signaling pathway. This compound effectively inhibits the activity of full-length β-lactamase, providing a valuable tool for studies related to antibiotic resistance. Its mechanism of action makes it suitable for research applications focused on bacterial infections and the development of novel therapeutic strategies. -
Anti-HIV Agent
Moronic Acid is a triterpenoid compound that serves as an orally available anti-HIV agent, exhibiting significant anti-inflammatory properties. It demonstrates the ability to inhibit viral replication, with an EC50 value of less than 1 μg/mL. Moronic Acid can be isolated from Brazilian propolis and is utilized in research focused on HIV treatment and related viral studies. -
Antitumor/ Antibacterial Agent
Epanorin is a secondary metabolite derived from the Acarospora lichenic species, primarily targeting tumor cells and bacterial pathogens. It exhibits potent antitumor activity by inhibiting cancer cell proliferation, reducing reactive oxygen species (ROS) production, and inducing cell cycle arrest in the G0/G1 phase. Additionally, Epanorin demonstrates antibacterial properties, making it valuable for research applications focused on cancer treatment and bacterial infections, including studies on breast cancer and Streptococcus pneumoniae infections. -
Antibacterial Agent
Deoxymikanolide is an orally active antibacterial agent that primarily targets catalase (CAT), peroxidase (POD), and superoxide dismutase (SOD) activities. It enhances glycan and phosphorus metabolism, increases electrical conductivity, and elevates levels of intrabacterial reactive oxygen species (ROS) and malondialdehyde (MDA). These actions result in cell shrinkage, cytoplasmic damage, and disruption in Ralstonia solanacearum. Additionally, Deoxymikanolide demonstrates efficacy in inhibiting acetic acid-induced writhing in mice, making it a valuable tool for research on bacterial wilt. -
Antibacterial Peptide
KSL-W is a multifunctional antibacterial peptide primarily targeting immune regulation. It exhibits significant chemotactic effects on neutrophils and promotes F-actin polymerization through the Gαi protein signaling pathway. Additionally, KSL-W effectively inhibits the production of reactive oxygen species (ROS) in neutrophils. This peptide is valuable for research focused on infection control and the regulation of inflammatory processes. -
Antileishmanial Agent
PT4 is an antileishmanial agent specifically effective against cutaneous leishmaniasis. It exhibits significant activity against both Leishmania species, with IC50 values of 125.18 µM for L. amazonensis and 233.18 µM for L. braziliensis. PT4 induces a reduction in mitochondrial membrane potential and elevates reactive oxygen species production, resulting in parasite lethality. Additionally, PT4 demonstrates potent in vivo anti-inflammatory properties, making it a valuable tool for research in leishmaniasis and related inflammatory conditions. -
Antibacterial Agent
Aloe vera, a natural herbal extract, exhibits significant antibacterial activity. It is recognized for its anti-inflammatory and antioxidant properties, making it a valuable candidate for research applications in areas such as tumor biology, diabetes, bone disorders, and cardiovascular health. Its diverse biological effects support its potential use as a therapeutic agent in various biomedical studies. -
Antibacterial Agent
ROS inducer 9 is an antibacterial agent that functions by inhibiting glutathione (GSH) activity and elevating reactive oxygen species (ROS) levels. With a minimum inhibitory concentration (MIC) of 0.25 μg/mL against E. coli, it demonstrates potent antibacterial properties. Additionally, ROS inducer 9 exhibits low toxicity to erythrocytes and RAW 264.7 cells, making it suitable for various biological research applications in exploring oxidative stress responses in bacterial infections. -
Anti-bacterial Agent
Anti-MRSA agent 36 is an antibacterial compound that exhibits potent activity against methicillin-resistant Staphylococcus aureus (MRSA), with a minimum inhibitory concentration (MIC) of 1 μg/mL. This agent specifically targets phosphatidylglycerol (PG) in bacterial membranes, leading to compromised membrane integrity, DNA leakage, and increased reactive oxygen species (ROS) production. Characterized by low cytotoxicity and minimal hemolytic effect, Anti-MRSA agent 36 also demonstrates a reduced propensity for inducing drug resistance and good plasma stability, making it suitable for research involving skin abscess and systemic infection models. -
Antibacterial Agent
Antibacterial Agent 308 is an antibacterial compound that selectively targets bacterial membranes by binding to phosphatidylethanolamine, leading to membrane polarization disruption and increased intracellular reactive oxygen species (ROS) levels. This agent exhibits significant anti-biofilm activity against Staphylococcus aureus and demonstrates potent anti-methicillin-resistant Staphylococcus aureus (MRSA) efficacy. Its unique mechanism makes it a valuable tool for research focused on combating bacterial infections and biofilm-related challenges. -
Superoxide Anion Inhibitor
Tanzawaic acid B is a potent inhibitor of superoxide anion production, derived from the fungal source Penicillium citrinum. This compound has been demonstrated to mitigate oxidative stress by targeting superoxide radicals, making it valuable for research in oxidative damage and related pathologies. Its biological activity provides a useful tool for studying the effects of reactive oxygen species in various cellular models. -
Antileishmanial Agent
Antileishmanial agent-35 is a potent antileishmanial compound that targets Leishmania amazonensis, exhibiting an IC50 of 0.29 μM against promastigotes. This compound disrupts mitochondrial function by lowering the mitochondrial membrane potential and ATP levels, while also enhancing reactive oxygen species (ROS) production due to interference with the electron transport chain. Antileishmanial agent-35 is suitable for research focused on cutaneous leishmaniasis and its underlying mechanisms of action. -
Antibiotic
TAN-420E (Dihydroherbimycin A) is an antibiotic derived from the fermentation of Streptomyces hygroscopicus. This compound demonstrates significant cytotoxicity against P-388 and KB cancer cell lines, highlighting its potential as an anti-cancer agent. In addition, TAN-420E effectively scavenges DPPH free radicals, with an IC50 value of 1.3 μM, indicating its potential antioxidant properties. Research applications include investigations into its antimicrobial and anticancer effects. -
Glycylcycline Antibiotic
Tigecycline hydrate is a glycylcycline antibiotic characterized by its broad-spectrum antibacterial activity. It exhibits significant inhibitory effects against various bacterial strains, with a mean inhibitory concentration (MIC) of approximately 125 ng/mL for E. coli (MG1655 strain). In addition, it displays MIC50 and MIC90 values of 1 mg/L and 2 mg/L, respectively, for Acinetobacter baumannii. This compound is valuable for research applications related to antibiotic efficacy and resistance studies. -
Antibacterial Agent
3,4-Dimethoxychalcone acts as an antibacterial agent by inducing deacetylation of cytoplasmic proteins, thereby promoting autophagy flux. This compound is relevant for research applications focused on disease mechanisms related to cardiac and cancer biology, offering potential pathways for therapeutic intervention. Researchers may explore its effects on cellular processes and its role as a caloric restriction mimetic in various experimental models. -
HIV-1 RT Inhibitor
Apricitabine is a selective inhibitor of HIV-1 reverse transcriptase (RT) with a Ki value of 0.08 μM. It also exerts inhibitory effects on DNA polymerases α, β, and γ, with corresponding Ki values of 300 μM, 12 μM, and 112.25 μM. Demonstrating significant antiretroviral efficacy and favorable tolerability, Apricitabine shows a reduced potential for resistance development in patients with antiretroviral-naive HIV infection. This compound is applicable for research in the mechanisms of HIV-1 replication and antiviral drug development. -
Antibacterial Agent
BWC0977 is an antibacterial agent that primarily targets bacterial DNA replication by inhibiting DNA gyrase and topoisomerase IV. This compound demonstrates potent activity with a minimum inhibitory concentration (MIC90) ranging from 0.03 to 2 µg/mL against multi-drug resistant Gram-negative bacteria. BWC0977 is suitable for research applications involving the study of bacterial resistance mechanisms and the development of new antimicrobial strategies. -
Antibacterial Agent
BWC0977 formic is an antibacterial agent that targets bacterial DNA replication by inhibiting DNA gyrase and topoisomerase IV. It demonstrates significant antibacterial activity, with a minimum inhibitory concentration (MIC90) ranging from 0.03 to 2 µg/mL against multi-drug resistant Gram-negative bacteria. This compound is valuable for research applications focused on combating antibiotic resistance and exploring therapeutic strategies for resistant infections. -
Antibiotic
Rifaquizinone is a hybrid antibiotic that combines the mechanisms of Rifamycin and Quinolone. It effectively inhibits wild-type Staphylococcus aureus RNA polymerase, exhibiting an IC50 value of 34 nM. Rifaquizinone demonstrates potent antibacterial activity against S. aureus infections, with minimum inhibitory concentrations (MICs) ranging from 0.008 to 0.5 μg/mL across 300 clinical isolates of staphylococci and streptococci, making it a valuable tool for antibiotic research and investigation into resistance mechanisms. -
Antibiotic
Erythromycin (aspartate) is a macrolide antibiotic that exerts its effects by binding to the 50S ribosomal subunit of bacteria, inhibiting RNA-dependent protein synthesis through the blockage of transpeptidation and translocation reactions. This compound demonstrates a broad spectrum of antimicrobial activity, making it an important tool in microbiological research. Additionally, erythromycin aspartate has shown potential antitumor and neuroprotective properties, expanding its applications in various fields of biomedical research. -
Antiviral Agent
Onradivir monohydrate is an orally active antiviral agent that targets the influenza A virus RNA polymerase PB2 subunit, exhibiting an IC50 value of 0.562 nM. This compound effectively inhibits cap binding to the PB2 subunit, leading to suppression of viral replication, reduction of viral titers, and decreased RNA loads. In murine models, Onradivir monohydrate demonstrates improved survival rates in influenza A virus-infected mice and is a valuable tool for studying influenza A virus infections in research applications. -
Antibiotic
Alatrofloxacin is a fluoronaphthyridone antibiotic that serves as a proagent of Trovafloxacin. Its primary mechanism involves the inhibition of DNA synthesis in pathogenic organisms, resulting in effective antimicrobial activity. In addition to its antibacterial properties, Alatrofloxacin also exhibits immunosuppressive effects, making it relevant for research applications in studying immune responses and infectious diseases. -
HBV Inhibitor
HBV-IN-48 is a potent inhibitor of Hepatitis B Virus (HBV) with demonstrated antiviral activity. It effectively reduces viral replication in HepDE19 cells, achieving an EC50 value of 0.005 μM. Additionally, HBV-IN-48 has shown the ability to lower serum HBV DNA levels in mouse models, making it a valuable tool for studying HBV infections and potential therapeutic interventions. -
Antibiotic
Ficellomycin is a nitrogen-containing bicyclic antibiotic targeting Gram-positive bacteria, including multidrug-resistant Staphylococcus aureus. It exerts its biological activity by inducing the formation of defective 34S DNA fragments that disrupt the semi-conservative DNA replication process. These fragments are unable to integrate into larger DNA segments, ultimately hindering the assembly of a complete bacterial chromosome. Ficellomycin is valuable for research on bacterial diseases and antibiotic resistance mechanisms. -
DENV Inhibitor
DENV-IN-4 is a potent inhibitor of Dengue Virus (DENV), exhibiting an EC50 value of 4.79 µM in Vero cells with a selectivity index greater than 20.9. This compound effectively reduces the expression levels of DENV2 in a concentration-dependent manner and inhibits RNA-dependent RNA polymerase (RdRp) enzymatic activity. DENV-IN-4 is valuable for research applications focused on understanding DENV pathogenesis and developing antiviral therapies. -
HBV DNA Synthesis Inhibitor
LB80317 is an active metabolite of LB80380 that functions as a potent inhibitor of HBV DNA synthesis, exhibiting an EC50 of 0.5 μM. This compound demonstrates antiviral activity, making it a promising candidate for the treatment of chronic hepatitis B. Its ability to inhibit viral replication supports its potential utility in HBV research and therapeutic applications. -
Tetracycline derivatives of antibiotic
Sarecycline is a narrow-spectrum tetracycline derivative antibiotic that primarily targets bacterial protein synthesis by interfering with tRNA accommodation and stabilizing mRNA binding to the 70S ribosome. It exhibits significant anti-inflammatory activity and effectively inhibits the growth of Gram-positive bacteria, including various strains of keratobacterium acnes. Sarecycline is suitable for research applications focused on understanding moderate to severe acne and its underlying mechanisms. -
Antibacterial Agent
Antibacterial Agent 89 is a potent antibacterial compound that targets bacterial transcription processes. It exhibits significant anti-clostridial activity by inhibiting the release of cytotoxins and disrupting the β’CH-σ interaction. This compound is useful for research applications focused on bacterial pathogenesis and the development of novel antibacterial strategies. -
DNA Gyrase Inhibitor
DNA Gyrase-IN-11 is a selective inhibitor of DNA gyrase, targeting bacterial DNA replication and supercoiling mechanisms. It demonstrates a potent inhibitory effect on protein synthesis with an IC50 of 0.74 μM and effectively inhibits E. coli DNA gyrase with an IC50 of 11.9 μM. Additionally, DNA Gyrase-IN-11 possesses significant antibacterial activity against pathogens such as Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, and Staphylococcus aureus, with minimum inhibitory concentrations (MICs) ranging from 0.008 to 0.25 μg/mL, making it a valuable tool for antimicrobial research. -
HBV Inhibitor
HBV-IN-21 is a potent inhibitor of hepatitis B virus (HBV) DNA replication, exhibiting an IC50 of 2.2 µM. This compound demonstrates a strong interaction with the HBV core capsid protein, characterized by a dissociation constant (KD) of 60.0 μM. HBV-IN-21 is suited for research applications focused on antiviral drug development and elucidation of HBV replication mechanisms. -
DNA Synthesis/HSV/HIV-1 Inhibitor
16,16-Dimethyl prostaglandin A1 is a prostaglandin analog that primarily inhibits DNA synthesis. It demonstrates significant antiviral activity by reducing viral replication in both herpes simplex virus (HSV) and HIV-1 infection models. This compound serves as a valuable tool for research focused on cancer biology and viral pathogenesis. -
Fluoroquinolone Antibiotic
PD 124816 is an orally active fluoroquinolone antibiotic that inhibits DNA gyrase (topoisomerase IV), providing broad-spectrum antibacterial activity. It demonstrates efficacy against both Gram-positive and Gram-negative bacteria, with a minimum inhibitory concentration (MIC₉₀) of ≤ 0.06 μg/mL and an MIC₉₀ of 1 μg/mL for anaerobic bacteria such as Peptostreptococcus fragi. Additionally, PD 124816 exhibits complete bactericidal effectiveness in a mouse model of Mycobacterium leprae infection. This compound is valuable for research involving mixed infections and antibiotic resistance mechanisms. -
DENV/ZIKV Inhibitor
Antiviral agent 36 is a potent inhibitor of dengue virus (DENV) and Zika virus (ZIKV), demonstrating effective antiviral activity. It inhibits viral replication with EC50 values of 100 nM for ZIKV-FLR, 90 nM for ZIKV-HN16, 210 nM for DENV-2, and 120 nM for DENV-3. This compound serves as a valuable tool for research focused on the therapeutic development and understanding of DENV and ZIKV infections. -
Anti SARS-CoV-2 Agent
DMA-155 is an antiviral agent that targets SARS-CoV-2 by binding to 5'-terminal stem-loop RNAs, demonstrating affinities of 51.1 μM (SL1), 61.1 μM (SL4), 54.5 μM (SL5a), 66.9 μM (SL5b), and 48.6 μM (SL6). This compound effectively inhibits SARS-CoV-2 viral replication and significantly reduces viral RNA levels. DMA-155 is suitable for research applications related to COVID-19. -
Antitumor Antibiotic
Esperamicin A1 is a highly potent antitumor antibiotic derived from Actinomadura verrucosospora. It exhibits significant cytotoxic activity, making it valuable for cancer research applications. In addition to its antitumor properties, Esperamicin A1 functions as a click chemistry reagent, featuring an alkyne group that enables copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing molecules. This allows for versatile applications in bioconjugation and molecular imaging studies.
